What is the current valuation of the cas9 technology market in South Korea?

The market valuation was $138.6 Million in 2024. Read More

What is the projected market valuation for the cas9 technology market by 2035?

The projected valuation for 2035 is $479.43 Million. Read More

What is the expected CAGR for the South Korea cas9 technology market during 2025 - 2035?

The expected CAGR during this period is 11.94%. Read More

What are the main product types in the cas9 technology market?

Main product types include consumables and vectors, with consumables valued at $245 Million in 2024. Read More

What applications are driving growth in the cas9 technology market?

Applications such as genome engineering and disease models are significant, with genome engineering valued at $192.12 Million. Read More

What delivery methods are utilized in the cas9 technology market?

Delivery methods include physical, viral, and non-viral methods, with non-viral methods valued at $229.43 Million. Read More

Who are the primary end users of cas9 technology?

Primary end users are biotechnology & pharmaceutical companies and academic & research institutes. Read More

How did the market perform in terms of vectors in 2024?

In 2024, the vectors segment was valued at $234.43 Million. Read More

What is the potential for growth in the cas9 technology market in South Korea?

The market appears poised for growth, with a projected valuation increase to $479.43 Million by 2035. Read More

South Korea Cas9 Technology Market

Q: Which companies are considered key players in the cas9 technology market?

Key players include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and others. Read More

ID: MRFR/ICT/63080-HCR

200 Pages

Aarti Dhapte

Last Updated: February 06, 2026

South Korea Cas9 Technology Market Size, Share and Trends Analysis Report By Application (Genome Engineering, Disease Models, In Vitro Genetic Depletion), By Product Type (Consumables, Vectors), By Delivery Method (Physical Delivery Methods, Viral Delivery Methods, Non-Viral Delivery Methods) and By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes)- Forecast to 2035

South Korea Cas9 Technology Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)11.94%

2024 Market Size$ 138.6 Million

2025 Market Size$ 155.15 Million

2035 Market Size$ 479.43 Million

Key Players

Editas Medicine

CRISPR Therapeutics

Intellia Therapeutics

Cellectis

Caribou Biosciences

Regeneron Pharmaceuticals

Trends

Increased Investment in Biotechnology
Regulatory Evolution
Focus on Agricultural Applications

Opportunities

Rising Demand for Precision Medicine
Growing Public Awareness and Acceptance
Advancements in Agricultural Biotechnology

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Information and Communications Technology, BY Product Type (USD Million)
  1. 4.1.1 Consumables
  2. 4.1.2 Vectors
2. 4.2 Information and Communications Technology, BY Application (USD Million)
  1. 4.2.1 Genome Engineering
  2. 4.2.2 Disease Models
  3. 4.2.3 In Vitro Genetic Depletion
3. 4.3 Information and Communications Technology, BY Delivery Method (USD Million)
  1. 4.3.1 Physical Delivery Methods
  2. 4.3.2 Viral Delivery Methods
  3. 4.3.3 Non-Viral Delivery Methods
4. 4.4 Information and Communications Technology, BY End User (USD Million)
  1. 4.4.1 Biotechnology & Pharmaceutical Companies
  2. 4.4.2 Academic & Research Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Information and Communications Technology
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Information and Communications Technology
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Editas Medicine (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 CRISPR Therapeutics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Intellia Therapeutics (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cellectis (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Caribou Biosciences (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Regeneron Pharmaceuticals (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Beam Therapeutics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Precision BioSciences (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY DELIVERY METHOD
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
9. 6.9 DRIVERS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
11. 6.11 SUPPLY / VALUE CHAIN: INFORMATION AND COMMUNICATIONS TECHNOLOGY
12. 6.12 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 (% SHARE)
15. 6.15 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 (% SHARE)
17. 6.17 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DELIVERY METHOD, 2024 TO 2035 (USD Million)
18. 6.18 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 (% SHARE)
19. 6.19 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY DELIVERY METHOD, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea South Korea Cas9 Technology Market Segmentation

South Korea Cas9 Technology Market By Product Type (USD Million, 2025-2035)

Consumables
Vectors

South Korea Cas9 Technology Market By Application (USD Million, 2025-2035)

Genome Engineering
Disease Models
In Vitro Genetic Depletion

South Korea Cas9 Technology Market By Delivery Method (USD Million, 2025-2035)

Physical Delivery Methods
Viral Delivery Methods
Non-Viral Delivery Methods

South Korea Cas9 Technology Market By End User (USD Million, 2025-2035)

Biotechnology & South Korea Cas9 Technology Market Companies
Academic & Research Institutes

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”